Bilaketaren emaitzak - Colleen M. Niswender

Findu emaitzak
  1. 1
    RNA Editing of the Human Serotonin 5-HT2C Receptor Alterations in Suicide and Implications for Serotonergic Pharmacotherapy

    RNA Editing of the Human Serotonin 5-HT2C Receptor Alterations in Suicide and Implications for Serotonergic Pharmacotherapy nork Colleen M. Niswender

    Argitaratua 2001
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications

    Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications nork Yin Shen, Colleen M. Niswender

    Argitaratua 2014
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease

    Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease nork Colleen M. Niswender, P. Jeffrey Conn

    Argitaratua 2010
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Serotonin 5‐HT<sub>2C</sub> Receptor RNA Editing Alters Receptor Basal Activity

    Serotonin 5‐HT<sub>2C</sub> Receptor RNA Editing Alters Receptor Basal Activity nork Katharine Herrick‐Davis, Ellinor Grinde, Colleen M. Niswender

    Argitaratua 1999
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Novel pharmacological targets for GABAergic dysfunction in ADHD

    Novel pharmacological targets for GABAergic dysfunction in ADHD nork Anthony S. Ferranti, Deborah J. Luessen, Colleen M. Niswender

    Argitaratua 2024
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Mglur4-Positive Allosteric Modulation as Potential Treatment for Parkinson’s Disease

    Mglur4-Positive Allosteric Modulation as Potential Treatment for Parkinson’s Disease nork Corey R. Hopkins, Craig W. Lindsley, Colleen M. Niswender

    Argitaratua 2009
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Glutamate Receptors as Therapeutic Targets for Parkinsons Disease

    Glutamate Receptors as Therapeutic Targets for Parkinsons Disease nork Kari A. Johnson, P. Jeffrey Conn, Colleen M. Niswender

    Argitaratua 2009
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders

    Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders nork P. Jeffrey Conn, Craig W. Lindsley, Jens Meiler, Colleen M. Niswender

    Argitaratua 2014
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders

    Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders nork Nicole M. Fisher, Mabel Seto, Craig W. Lindsley, Colleen M. Niswender

    Argitaratua 2018
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Group III mGluR regulation of synaptic transmission at the SC-CA1 synapse is developmentally regulated

    Group III mGluR regulation of synaptic transmission at the SC-CA1 synapse is developmentally regulated nork Jennifer Ayala, Colleen M. Niswender, Qingwei Luo, Jessica L. Banko, P. Jeffrey Conn

    Argitaratua 2007
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    RNA Editing of the Human Serotonin 5-Hydroxytryptamine 2C Receptor Silences Constitutive Activity

    RNA Editing of the Human Serotonin 5-Hydroxytryptamine 2C Receptor Silences Constitutive Activity nork Colleen M. Niswender, Sara C. Copeland, Katharine Herrick‐Davis, Ronald B. Emeson, Elaine Sanders‐Bush

    Argitaratua 1999
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    RNA‐editing of the 5‐HT<sub>2C</sub> receptor alters agonist‐receptor‐effector coupling specificity

    RNA‐editing of the 5‐HT<sub>2C</sub> receptor alters agonist‐receptor‐effector coupling specificity nork Kelly A. Berg, Jodie Cropper, Colleen M. Niswender, Elaine Sanders‐Bush, Ronald B. Emeson, William P. Clarke

    Argitaratua 2001
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Discovery of a Novel Chemical Class of mGlu<sub>5</sub> Allosteric Ligands with Distinct Modes of Pharmacology

    Discovery of a Novel Chemical Class of mGlu<sub>5</sub> Allosteric Ligands with Distinct Modes of Pharmacology nork Alexis S. Hammond, Alice L. Rodriguez, Steven D. Townsend, Colleen M. Niswender, Karen J. Gregory, Craig W. Lindsley, P. Jeffrey Conn

    Argitaratua 2010
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors

    Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors nork Craig W. Lindsley, Kyle A. Emmitte, Corey R. Hopkins, Thomas M. Bridges, Karen J. Gregory, Colleen M. Niswender, P. Jeffrey Conn

    Argitaratua 2016
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Total RNA Sequencing of Rett Syndrome Autopsy Samples Identifies the M<sub>4</sub> Muscarinic Receptor as a Novel Therapeutic Target

    Total RNA Sequencing of Rett Syndrome Autopsy Samples Identifies the M<sub>4</sub> Muscarinic Receptor as a Novel Therapeutic Target nork Rocco G. Gogliotti, Nicole M. Fisher, Branden J. Stansley, Carrie K. Jones, Craig W. Lindsley, P. Jeffrey Conn, Colleen M. Niswender

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Selective Actions of Novel Allosteric Modulators Reveal Functional Heteromers of Metabotropic Glutamate Receptors in the CNS

    Selective Actions of Novel Allosteric Modulators Reveal Functional Heteromers of Metabotropic Glutamate Receptors in the CNS nork Yin Shen, Meredith J. Noetzel, Kari A. Johnson, Rocio Zamorano, Nidhi Jalan‐Sakrikar, Karen J. Gregory, P. Jeffrey Conn, Colleen M. Niswender

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery

    Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery nork Bruce J. Melancon, Corey R. Hopkins, Michael R. Wood, Kyle A. Emmitte, Colleen M. Niswender, Arthur Christopoulos, P. Jeffrey Conn, Craig W. Lindsley

    Argitaratua 2011
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction

    Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction nork Adam G. Walker, Cody J. Wenthur, Zixiu Xiang, Jerri M. Rook, Kyle A. Emmitte, Colleen M. Niswender, Craig W. Lindsley, P. Jeffrey Conn

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    A Novel Class of Succinimide-Derived Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 1 Provides Insight into a Disconnect in Activity between the Rat and Human Receptors

    A Novel Class of Succinimide-Derived Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 1 Provides Insight into a Disconnect in Activity between the Rat and... nork Hyekyung P. Cho, Darren W. Engers, Daryl F. Venable, Colleen M. Niswender, Craig W. Lindsley, P. Jeffrey Conn, Kyle A. Emmitte, Alice L. Rodriguez

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Synthesis and Evaluation of a Series of Heterobiarylamides That Are Centrally Penetrant Metabotropic Glutamate Receptor 4 (mGluR4) Positive Allosteric Modulators (PAMs)

    Synthesis and Evaluation of a Series of Heterobiarylamides That Are Centrally Penetrant Metabotropic Glutamate Receptor 4 (mGluR4) Positive Allosteric Modulators (PAMs) nork Darren W. Engers, Colleen M. Niswender, C. David Weaver, Satyawan Jadhav, Usha N. Menon, Rocio Zamorano, P. Jeffrey Conn, Craig W. Lindsley, Corey R. Hopkins

    Argitaratua 2009
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: